Anna Valerianova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Anna Valerianova has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Jan Malik
Third Department of Internal Medicine, First Faculty of Medicine, General University Hospital in Prague, Charles University
13 shared publications - Vladimir Tesar
General University Hospital, Charles University, Prague, Czech Republic
5 shared publications - Zdenka Hruskova
Department of Nephrology, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
4 shared publications Jana Lachmanova
Department of Nephrology, 1(st) Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08 Prague, Czech Republic
3 shared publications- Jaroslav Kudlicka
3rd Department of Internal Medicine, General University Hospital and 1st Faculty of Medicine, Charles University , Prague, Czech Republic
3 shared publications Katarina Rocinova
Dialysis Center Cerny Most, B. Braun Avitum
3 shared publications
Latest Publications
- Open Access
- 4 March 2026
- Published by Taylor & Francis in Renal Failure
- Vol. 48 (1) , 2624915
Negative impact of very mild volume overload on the heart function in patients on chronic hemodialysis
Heart failure is associated with higher mortality of hemodialysis patients. Fluid overload is a major risk factor for cardiovascular disease in these patients, but it is frequently clinically silent. The optimal assessment of ideal dry weight is still searched for. We hypothesized that even very mild fluid overload would be associated with the left ventricular ejection fraction and on the size of heart chambers. Inclusion visit data of a cohort observation study were analyzed: bioelectrical impedance, echocardiography with hemodynamic estimations and basic laboratory tests. Fluid overload was defined by using the fluid overload/extracellular water index (FO/ECW, relative hydration index) > median value. Moreover, analyses according to FO/ECW quartiles were performed. All these measurements were done within an hour and at least 24 h after the previous hemodialysis. We included 334 patients. FO/ECW median was 7%. Patients with fluid overload had lower left ventricular ejection fraction (median (interquartile range): 53(45-62) vs. 60(56-67)%, p = 0.0002), dilatation of all heart chambers, more pronounced hypertrophy of the left ventricle with higher NTproBNP, significantly lower serum albumin levels and lower body mass. The relationship between the relative hydration index and heart changes was gradual. Fluid overload, as defined by the mild criteria, was associated with a worse ejection fraction, but also with other functional and structural heart changes. Our study demonstrates that in patients on dialysis, even mild (often subclinical) fluid overload is associated with structural and functional heart changes. Early identification of fluid overload with improved methods of volume assessment is thus warranted and especially in lean patients.
- 4 March 2026
- Published by Taylor & Francis in Renal Failure
- Vol. 48 (1) , 2624915
Open AccessNegative impact of very mild volume overload on the heart function in patients on chronic hemodialysis
Heart failure is associated with higher mortality of hemodialysis patients. Fluid overload is a major risk factor for cardiovascular disease in these patients, but it is frequently clinically silent. The optimal assessment of ideal dry weight is still searched for. We hypothesized that even very mild fluid overload would be associated with the left ventricular ejection fraction and on the size of heart chambers. Inclusion visit data of a cohort observation study were analyzed: bioelectrical impedance, echocardiography with hemodynamic estimations and basic laboratory tests. Fluid overload was defined by using the fluid overload/extracellular water index (FO/ECW, relative hydration index) > median value. Moreover, analyses according to FO/ECW quartiles were performed. All these measurements were done within an hour and at least 24 h after the previous hemodialysis. We included 334 patients. FO/ECW median was 7%. Patients with fluid overload had lower left ventricular ejection fraction (median (interquartile range): 53(45-62) vs. 60(56-67)%, p = 0.0002), dilatation of all heart chambers, more pronounced hypertrophy of the left ventricle with higher NTproBNP, significantly lower serum albumin levels and lower body mass. The relationship between the relative hydration index and heart changes was gradual. Fluid overload, as defined by the mild criteria, was associated with a worse ejection fraction, but also with other functional and structural heart changes. Our study demonstrates that in patients on dialysis, even mild (often subclinical) fluid overload is associated with structural and functional heart changes. Early identification of fluid overload with improved methods of volume assessment is thus warranted and especially in lean patients.
- Open Access
- 24 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 114
How to Define High-Flow Arteriovenous Fistula? Comment on Kim et al. Hemodynamic Adaptation and Cardiac Effects of High-Flow Arteriovenous Access in Hemodialysis Patients: A Prospective Study. J. Clin. Med. 2025, 14, 4556
We have read the manuscript by Yaeni Kim et al
- 24 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 114
Open AccessHow to Define High-Flow Arteriovenous Fistula? Comment on Kim et al. Hemodynamic Adaptation and Cardiac Effects of High-Flow Arteriovenous Access in Hemodialysis Patients: A Prospective Study. J. Clin. Med. 2025, 14, 4556
We have read the manuscript by Yaeni Kim et al
- Open Access
- 17 July 2024
- Published by Elsevier in Resuscitation
- Vol. 202, 110319
EEG for good outcome prediction after cardiac arrest: A multicentre cohort study
- 17 July 2024
- Published by Elsevier in Resuscitation
- Vol. 202, 110319
Open AccessEEG for good outcome prediction after cardiac arrest: A multicentre cohort study
- 30 January 2024
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 26 (4) , 103-109
Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy
Purpose of Review Chronic kidney disease (CKD) is associated with a significantly increased risk of cardiovascular disease (CVD). This review summarizes known risk factors, pathophysiological mechanisms, and current therapeutic possibilities, focusing on lipid-lowering therapy in CKD. Recent Findings Novel data on lipid-lowering therapy in CKD mainly stem from clinical trials and clinical studies. Summary In addition to traditional CVD risk factors, patients with CKD often present with non-traditional risk factors that include, e.g., anemia, proteinuria, or calcium-phosphate imbalance. Dyslipidemia remains an important contributing CVD risk factor in CKD, although the mechanisms involved differ from the general population. While statins are the most commonly used lipid-lowering therapy in CKD patients, some statins may require dose reduction. Importantly, statins showed diminished beneficial effect on cardiovascular events in patients with severe CKD and hypercholesterolemia despite high CVD risk and effective reduction of LDL cholesterol. Ezetimibe enables the reduction of the dose of statins and their putative toxicity and, in combination with statins, reduces CVD endpoints in CKD patients. The use of novel drugs such as PCSK9 inhibitors is safe in CKD, but their potential to reduce cardiovascular events in CKD needs to be elucidated in future studies.
- 30 January 2024
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 26 (4) , 103-109
Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy
Purpose of Review Chronic kidney disease (CKD) is associated with a significantly increased risk of cardiovascular disease (CVD). This review summarizes known risk factors, pathophysiological mechanisms, and current therapeutic possibilities, focusing on lipid-lowering therapy in CKD. Recent Findings Novel data on lipid-lowering therapy in CKD mainly stem from clinical trials and clinical studies. Summary In addition to traditional CVD risk factors, patients with CKD often present with non-traditional risk factors that include, e.g., anemia, proteinuria, or calcium-phosphate imbalance. Dyslipidemia remains an important contributing CVD risk factor in CKD, although the mechanisms involved differ from the general population. While statins are the most commonly used lipid-lowering therapy in CKD patients, some statins may require dose reduction. Importantly, statins showed diminished beneficial effect on cardiovascular events in patients with severe CKD and hypercholesterolemia despite high CVD risk and effective reduction of LDL cholesterol. Ezetimibe enables the reduction of the dose of statins and their putative toxicity and, in combination with statins, reduces CVD endpoints in CKD patients. The use of novel drugs such as PCSK9 inhibitors is safe in CKD, but their potential to reduce cardiovascular events in CKD needs to be elucidated in future studies.
- Open Access
- 16 August 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (8) , 1979
Arteriovenous Hemodialysis Access Stenosis Diagnosed by Duplex Doppler Ultrasonography: A Review
Arteriovenous fistula (AVF) is currently the hemodialysis access with the longest life expectations for the patients. However, even the AVF is at risk for many complications, especially the development of stenosis. The latter can not only lead to inadequate hemodialysis but also lead to AVF thrombosis. Duplex Doppler ultrasonography is a very precise method, in the hands of experienced professionals, for the diagnosis of AVF complications. In this review, we summarize the ultrasound diagnostic criteria of significant stenoses and their indication for procedural therapy.
- 16 August 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (8) , 1979
Open AccessArteriovenous Hemodialysis Access Stenosis Diagnosed by Duplex Doppler Ultrasonography: A Review
Arteriovenous fistula (AVF) is currently the hemodialysis access with the longest life expectations for the patients. However, even the AVF is at risk for many complications, especially the development of stenosis. The latter can not only lead to inadequate hemodialysis but also lead to AVF thrombosis. Duplex Doppler ultrasonography is a very precise method, in the hands of experienced professionals, for the diagnosis of AVF complications. In this review, we summarize the ultrasound diagnostic criteria of significant stenoses and their indication for procedural therapy.
- Open Access
- 27 April 2022
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 13, 881658
New Porcine Model of Arteriovenous Fistula Documents Increased Coronary Blood Flow at the Cost of Brain Perfusion
Background: Arteriovenous fistulas (AVF) represent a low resistant circuit. It is known that their opening leads to decreased systemic vascular resistance, increased cardiac output and other hemodynamic changes. Possible competition of AVF and perfusion of other organs has been observed before, however the specific impact of AVF has not been elucidated yet. Previous animal models studied long-term changes associated with a surgically created high flow AVF. The aim of this study was to create a simple AVF model for the analysis of acute hemodynamic changes.Methods: Domestic female pigs weighing 62.6 ± 5.2 kg were used. All the experiments were held under general anesthesia. The AVF was created using high-diameter ECMO cannulas inserted into femoral artery and vein. Continuous hemodynamic monitoring was performed throughout the protocol. Near-infrared spectroscopy sensors, flow probes and flow wires were inserted to study brain and heart perfusion.Results: AVF blood flow was 2.1 ± 0.5 L/min, which represented around 23% of cardiac output. We observed increase in cardiac output (from 7.02 ± 2.35 L/min to 9.19 ± 2.99 L/min, p = 0.0001) driven dominantly by increased heart rate, increased pulmonary artery pressure, and associated right ventricular work. Coronary artery flow velocity rose. On the contrary, carotid artery flow and brain and muscle tissue oxygenation measured by NIRS decreased significantly.Conclusions: Our new non-surgical AVF model is reproducible and demonstrated an acute decrease of brain and muscle perfusion.
- 27 April 2022
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 13, 881658
Open AccessNew Porcine Model of Arteriovenous Fistula Documents Increased Coronary Blood Flow at the Cost of Brain Perfusion
Background: Arteriovenous fistulas (AVF) represent a low resistant circuit. It is known that their opening leads to decreased systemic vascular resistance, increased cardiac output and other hemodynamic changes. Possible competition of AVF and perfusion of other organs has been observed before, however the specific impact of AVF has not been elucidated yet. Previous animal models studied long-term changes associated with a surgically created high flow AVF. The aim of this study was to create a simple AVF model for the analysis of acute hemodynamic changes.Methods: Domestic female pigs weighing 62.6 ± 5.2 kg were used. All the experiments were held under general anesthesia. The AVF was created using high-diameter ECMO cannulas inserted into femoral artery and vein. Continuous hemodynamic monitoring was performed throughout the protocol. Near-infrared spectroscopy sensors, flow probes and flow wires were inserted to study brain and heart perfusion.Results: AVF blood flow was 2.1 ± 0.5 L/min, which represented around 23% of cardiac output. We observed increase in cardiac output (from 7.02 ± 2.35 L/min to 9.19 ± 2.99 L/min, p = 0.0001) driven dominantly by increased heart rate, increased pulmonary artery pressure, and associated right ventricular work. Coronary artery flow velocity rose. On the contrary, carotid artery flow and brain and muscle tissue oxygenation measured by NIRS decreased significantly.Conclusions: Our new non-surgical AVF model is reproducible and demonstrated an acute decrease of brain and muscle perfusion.
- 26 January 2022
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 24 (3) , 143-151
Wall Shear Stress Alteration: a Local Risk Factor of Atherosclerosis
Purpose of Review Wall shear stress describes the mechanical influence of blood flow on the arterial wall. In this review, we discuss the role of the wall shear stress in the development of atherosclerosis and its complications. Recent Findings Areas with chronically low, oscillating wall shear stress are most prone to plaque development and include outer bifurcation walls and inner walls of arches. In some diseases, patients have lower wall shear stress even in straight arterial segments; also, these findings were associated with atherosclerosis. High wall shear stress develops in the distal part (shoulder) of a stenosis and contributes to plaque destabilization. Summary Wall shear stress changes are involved in the development of atherosclerosis. They are not fully understood yet and act in concert with tangential wall stress.
- 26 January 2022
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 24 (3) , 143-151
Wall Shear Stress Alteration: a Local Risk Factor of Atherosclerosis
Purpose of Review Wall shear stress describes the mechanical influence of blood flow on the arterial wall. In this review, we discuss the role of the wall shear stress in the development of atherosclerosis and its complications. Recent Findings Areas with chronically low, oscillating wall shear stress are most prone to plaque development and include outer bifurcation walls and inner walls of arches. In some diseases, patients have lower wall shear stress even in straight arterial segments; also, these findings were associated with atherosclerosis. High wall shear stress develops in the distal part (shoulder) of a stenosis and contributes to plaque destabilization. Summary Wall shear stress changes are involved in the development of atherosclerosis. They are not fully understood yet and act in concert with tangential wall stress.
- Open Access
- 1 July 2021
- Published by Elsevier in International Journal of Cardiology
- Vol. 334, 148-153
Reduction of arteriovenous access blood flow leads to biventricular unloading in haemodialysis patients
- 1 July 2021
- Published by Elsevier in International Journal of Cardiology
- Vol. 334, 148-153
Open AccessReduction of arteriovenous access blood flow leads to biventricular unloading in haemodialysis patients
- Open Access
- 23 March 2021
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 8 (3) , 2165-2171
The Effect of High-Flow Arteriovenous Fistulas on Systemic Haemodynamics and Brain Oxygenation
Aims High‐flow arteriovenous fistula (AVF) for haemodialysis leads to profound haemodynamic changes and sometimes to heart failure (HF). Cardiac output (CO) is divided between the AVF and body tissues. The term effective CO (COef) represents the difference between CO and AVF flow volume (Qa) and better characterizes the altered haemodynamics that may result in organ hypoxia. We investigated the effects of Qa reduction on systemic haemodynamics and on brain oxygenation. Methods and results This is a single‐centre interventional study. Twenty‐six patients on chronic haemodialysis with high Qa (>1500 mL/min) were indicated for surgical Qa reduction for HF symptoms and/or signs of structural heart disease on echocardiography. The included patients underwent three sets of examinations: at 4 months and then 2 days prior and 6 weeks post‐surgical procedure. Clinical status, echocardiographical haemodynamic assessment, Qa, and brain oximetry were recorded. All parameters remained stable from selection to inclusion. After the procedure, Qa decreased from 3.0 ± 1.4 to 1.3 ± 0.5 L/min, P < 0.00001, CO from 7.8 ± 1.9 to 6.6 ± 1.5 L/min, P = 0.0002, but COef increased from 4.6 ± 1.4 to 5.3 ± 1.4 L/min, P = 0.036. Brain tissue oxygen saturation increased from 56 ± 11% to 60 ± 9%, P = 0.001. Conclusions Qa reduction led to increased COef. This was explained by a decreased proportion of CO running through the AVF in patients with Qa > 2.0 L/min. These observations were mirrored by higher brain oxygenation and might explain HF symptoms and improved haemodynamics even in asymptomatic high Qa patients.
- 23 March 2021
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 8 (3) , 2165-2171
Open AccessThe Effect of High-Flow Arteriovenous Fistulas on Systemic Haemodynamics and Brain Oxygenation
Aims High‐flow arteriovenous fistula (AVF) for haemodialysis leads to profound haemodynamic changes and sometimes to heart failure (HF). Cardiac output (CO) is divided between the AVF and body tissues. The term effective CO (COef) represents the difference between CO and AVF flow volume (Qa) and better characterizes the altered haemodynamics that may result in organ hypoxia. We investigated the effects of Qa reduction on systemic haemodynamics and on brain oxygenation. Methods and results This is a single‐centre interventional study. Twenty‐six patients on chronic haemodialysis with high Qa (>1500 mL/min) were indicated for surgical Qa reduction for HF symptoms and/or signs of structural heart disease on echocardiography. The included patients underwent three sets of examinations: at 4 months and then 2 days prior and 6 weeks post‐surgical procedure. Clinical status, echocardiographical haemodynamic assessment, Qa, and brain oximetry were recorded. All parameters remained stable from selection to inclusion. After the procedure, Qa decreased from 3.0 ± 1.4 to 1.3 ± 0.5 L/min, P < 0.00001, CO from 7.8 ± 1.9 to 6.6 ± 1.5 L/min, P = 0.0002, but COef increased from 4.6 ± 1.4 to 5.3 ± 1.4 L/min, P = 0.036. Brain tissue oxygen saturation increased from 56 ± 11% to 60 ± 9%, P = 0.001. Conclusions Qa reduction led to increased COef. This was explained by a decreased proportion of CO running through the AVF in patients with Qa > 2.0 L/min. These observations were mirrored by higher brain oxygenation and might explain HF symptoms and improved haemodynamics even in asymptomatic high Qa patients.
- Open Access
- 16 March 2021
- Published by Springer Nature
Heart failure in patients with advanced chronic kidney disease
- 16 March 2021
- Published by Springer Nature
Open AccessHeart failure in patients with advanced chronic kidney disease